C-MER Medical Holdings Limited (Stock code: 03309) submitted a Next Day Disclosure Return dated 3 November 2025. The filing indicates that, as of 31 October 2025, the company maintained 1,241,516,870 issued shares and 14,044,000 treasury shares (total 1,255,560,870 shares). On 3 November 2025, 320,000 shares were repurchased from the market at an average price of HKD 1.8083 per share and were designated as treasury shares. Consequently, the issued shares (excluding treasury) stood at 1,241,196,870, with 14,364,000 treasury shares remaining.

The filing also provides information on shares repurchased for cancellation but not yet cancelled across multiple dates from 2024 to 2025. Additionally, the repurchase report shows that on 3 November 2025, 320,000 shares were repurchased on the Exchange at a high of HKD 1.82 and a low of HKD 1.79, for a total settlement of HKD 578,660. All repurchased shares were placed in treasury rather than cancelled.

According to the filing, the current repurchase mandate was granted on 19 May 2025, allowing the company to repurchase up to 125,556,087 shares. The 320,000 shares repurchased on 3 November 2025 represent approximately 0.0258% of the number of issued shares (excluding treasury shares) as of the mandate date.